How to Handle Vascular Occlusion in Your Med Spa

What Is Vascular Occlusion?

Vascular occlusion occurs when dermal filler blocks a blood vessel, cutting off blood supply to surrounding tissue. It's one of the most serious complications in aesthetic medicine — and one of the most time-sensitive. Every med spa that performs filler treatments must have a written vascular occlusion protocol as part of their complete emergency protocol program.

The stakes are high:

• Untreated occlusion can lead to tissue necrosis (death)
• Periorbital occlusions can cause permanent blindness
• The window for effective treatment is 24-72 hours — and earlier is better
• Proper recognition and response can completely prevent permanent damage

How Common Is Vascular Occlusion?

The data varies, but published estimates suggest:

• Overall incidence: Approximately 1 in 6,000-10,000 filler injections
• Impending vision loss: Approximately 1 in 40,000-100,000 injections
• Higher risk areas: Nose (glabella), nasolabial folds, lips, tear troughs

A busy injector performing 50 filler treatments per week might encounter 2-4 vascular events over a 10-year career. It's rare enough that many practitioners never see one — but common enough that every practitioner should be prepared.

Anatomy: Why It Happens

High-Risk Zones

Glabella (between eyebrows): Supratrochlear and supraorbital arteries. Direct communication with ophthalmic artery. Highest risk for vision complications.

Nose: Dorsal nasal artery (branch of ophthalmic), angular artery. Complex anastomoses make occlusion particularly dangerous.

Nasolabial folds: Angular artery, superior labial artery. Common injection site = common occlusion site.

Lips: Superior and inferior labial arteries. High blood flow, but also high occlusion potential with product migration.

Mechanism of Occlusion

1. Direct intravascular injection: Product injected into a vessel
2. External compression: Product volume compresses adjacent vessels
3. Retrograde flow: Product pushes back into proximal vessels (especially concerning for vision)

Recognition: The First Critical Step

Early recognition is everything. Know these signs:

Immediate Signs (During Injection)

• Blanching: Skin turns white in a vascular pattern
• Pain: Severe, disproportionate pain during/after injection
• Dusky discoloration: Grayish, bluish, or mottled skin color
• Slow capillary refill: Press skin, takes >2 seconds to pink up

Vision-Related Signs (Emergency)

• Eye pain
• Vision changes (blurring, field loss)
• Pupil abnormalities
• Eye movement changes

If ANY vision symptoms appear: This is a medical emergency requiring immediate ophthalmology consultation and likely ER evaluation.

The Vascular Occlusion Response Protocol

Immediate Response (0-15 minutes)

1. Stop injection immediately — Do not inject more product. Remove needle/cannula.
2. Assess and document — Note exact location and extent of blanching. Time of onset. Photograph immediately.
3. Apply warm compress — Warm (not hot) compress to affected area. Promotes vasodilation. Do NOT use ice.
4. Administer hyaluronidase (for HA fillers) — Reconstitute if needed. Inject into and around affected area. Typical dose: 150-300 units initially, may repeat. Massage to disperse.
5. Consider aspirin — 325mg aspirin (if no contraindications). Discuss with Medical Director.
6. Massage — Gentle massage to affected area to help disperse product.
7. Nitroglycerin paste (if available) — Topical application promotes vasodilation. Medical Director approval required.

Follow-Up Response

First 24 hours: Monitor patient closely, may need repeat hyaluronidase, contact Medical Director, specialist consultation if not improving.

Days 2-7: Daily assessment (in-person preferred), photo documentation, wound care if tissue damage.

Hyaluronidase: Your Most Important Tool

For hyaluronic acid fillers, hyaluronidase is the antidote. Every practice performing HA filler injections should have it on hand.

Key points:

• Initial dose: 150-300 units injected into and around affected area
• May repeat: Every 30-60 minutes if not improving
• Distribution: Multiple small injections, massage to distribute

For non-HA fillers (Radiesse, Sculptra, Bellafill): Hyaluronidase will NOT dissolve these products. Focus on supportive care and lower threshold for specialist referral.

Prevention: The Best Protocol

Prevention starts with ensuring only qualified injectors perform filler treatments under proper medical supervision in Florida.

• Know the anatomy: High-risk zones require extra caution
• Slow injection: Inject slowly with minimal pressure
• Small aliquots: Never bolus large amounts
• Aspiration: Aspiration before injection adds a safety check
• Cannulas: May reduce risk in some areas
• Staged treatments: Less product per session reduces risk

When to Escalate

• Medical Director: Any suspected vascular occlusion — immediately
• Ophthalmology (Emergency): ANY vision symptoms, periorbital or glabellar occlusion
• Emergency Department: Vision involvement, systemic symptoms, patient instability
• Plastic/Vascular Surgery: Extensive tissue compromise, necrosis developing

Key Takeaways

1. Time is tissue — Early recognition and treatment save outcomes
2. Hyaluronidase is essential — Stock it, know how to use it
3. When in doubt, treat — Better to give hyaluronidase unnecessarily than to wait too long
4. Vision symptoms = emergency — Immediate ophthalmology and ER
5. Document everything — Protects everyone
6. Practice before you need it — Mock drills save real patients